Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Mohammed Orloff

Concepts (243)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Genetic Predisposition to Disease
12
2025
533
1.160
Why?
Germ-Line Mutation
9
2013
67
0.960
Why?
Hamartoma Syndrome, Multiple
8
2012
16
0.950
Why?
PTEN Phosphohydrolase
13
2015
55
0.930
Why?
Barrett Esophagus
2
2019
30
0.910
Why?
Esophageal Neoplasms
2
2019
113
0.830
Why?
Adenocarcinoma
3
2019
405
0.760
Why?
Haplotypes
3
2020
96
0.690
Why?
Polymorphism, Single Nucleotide
9
2021
505
0.600
Why?
Homozygote
3
2019
57
0.600
Why?
Carcinoma, Non-Small-Cell Lung
1
2020
175
0.560
Why?
Proto-Oncogene Proteins c-akt
4
2012
171
0.530
Why?
Databases, Factual
1
2020
742
0.500
Why?
Capacity Building
2
2025
26
0.420
Why?
Alleles
6
2021
277
0.410
Why?
Smoke-Free Policy
2
2025
17
0.410
Why?
Heart Defects, Congenital
3
2025
625
0.400
Why?
Lung Neoplasms
3
2020
645
0.400
Why?
Phosphatidylinositol 3-Kinases
2
2012
148
0.370
Why?
Genotype
6
2021
563
0.360
Why?
Extracellular Matrix Proteins
1
2011
69
0.340
Why?
Scavenger Receptors, Class A
1
2011
43
0.330
Why?
Case-Control Studies
6
2025
1212
0.330
Why?
Humans
40
2025
53246
0.290
Why?
Transcription Factors
1
2011
571
0.270
Why?
Genetic Variation
3
2021
223
0.270
Why?
Breast Neoplasms
7
2017
1223
0.260
Why?
Thyroid Neoplasms
4
2012
113
0.260
Why?
Inositol
1
2025
19
0.230
Why?
Tobacco Smoke Pollution
2
2025
56
0.230
Why?
Adult
18
2025
14541
0.230
Why?
Female
24
2025
28792
0.230
Why?
Limb Deformities, Congenital
1
2025
15
0.220
Why?
Genes, Wilms Tumor
1
2005
1
0.220
Why?
Population
1
2005
8
0.220
Why?
Gene Frequency
3
2020
97
0.220
Why?
Social Justice
1
2025
34
0.220
Why?
Glomerulosclerosis, Focal Segmental
1
2005
20
0.220
Why?
Genome
2
2019
58
0.220
Why?
Lamin Type A
1
2024
5
0.210
Why?
Evidence-Based Practice
1
2025
113
0.210
Why?
Middle Aged
17
2025
13422
0.210
Why?
Exome
2
2025
54
0.200
Why?
Linkage Disequilibrium
2
2020
41
0.190
Why?
Dietary Supplements
1
2025
479
0.180
Why?
Male
16
2025
27444
0.170
Why?
DNA Methylation
2
2024
592
0.170
Why?
Inheritance Patterns
1
2021
22
0.170
Why?
Phenotype
7
2021
803
0.160
Why?
Models, Genetic
5
2013
169
0.160
Why?
Risk Factors
5
2019
4018
0.160
Why?
Succinate Dehydrogenase
2
2011
22
0.160
Why?
Stilbenes
2
2010
58
0.160
Why?
Young Adult
9
2025
4514
0.160
Why?
Fires
1
2020
16
0.150
Why?
Aged
11
2020
10430
0.150
Why?
Agriculture
1
2020
19
0.150
Why?
Cluster Analysis
4
2013
238
0.150
Why?
Tobacco Products
1
2021
142
0.150
Why?
Social Media
1
2021
125
0.150
Why?
Aged, 80 and over
5
2020
3495
0.140
Why?
Arkansas
5
2025
2068
0.140
Why?
Genomics
1
2020
271
0.140
Why?
Cell Proliferation
3
2010
1031
0.140
Why?
Prostatic Neoplasms
2
2012
401
0.130
Why?
Pulmonary Disease, Chronic Obstructive
1
2020
152
0.130
Why?
Gene Expression Regulation, Neoplastic
3
2010
868
0.130
Why?
Prognosis
2
2020
2118
0.130
Why?
Endometrial Neoplasms
2
2015
143
0.120
Why?
Leprosy
1
2016
8
0.120
Why?
Hypertension
1
2021
554
0.120
Why?
Emergency Service, Hospital
1
2020
530
0.110
Why?
Asthma
1
2020
319
0.110
Why?
Regression Analysis
2
2017
391
0.110
Why?
Microsatellite Repeats
2
2012
41
0.110
Why?
Smoking
2
2025
526
0.110
Why?
Tuberculosis
1
2016
133
0.110
Why?
Aromatase
1
2015
9
0.110
Why?
Genetic Linkage
2
2011
25
0.100
Why?
Sirolimus
2
2010
72
0.100
Why?
Adolescent
8
2021
6912
0.100
Why?
Bone Morphogenetic Protein Receptors, Type I
1
2013
3
0.100
Why?
Genome-Wide Association Study
2
2012
184
0.100
Why?
Smad4 Protein
1
2013
6
0.100
Why?
Genetic Testing
2
2010
130
0.100
Why?
Cohort Studies
3
2012
1557
0.090
Why?
Class I Phosphatidylinositol 3-Kinases
1
2012
20
0.090
Why?
Colonic Polyps
1
2013
39
0.090
Why?
United States
4
2025
5413
0.090
Why?
Receptors, Cell Surface
1
2013
109
0.090
Why?
Mitochondrial Diseases
1
2012
45
0.090
Why?
Codon, Nonsense
1
2012
27
0.090
Why?
Flavin-Adenine Dinucleotide
1
2011
5
0.090
Why?
Antigens, CD
1
2013
217
0.090
Why?
NAD
1
2011
45
0.090
Why?
Genes, p53
1
2011
51
0.090
Why?
DNA, Neoplasm
1
2012
146
0.090
Why?
Mutation, Missense
1
2012
110
0.080
Why?
Siblings
1
2011
35
0.080
Why?
Adenoma
1
2012
114
0.080
Why?
Taxoids
1
2011
38
0.080
Why?
Risk
1
2012
306
0.080
Why?
Gene Expression Profiling
3
2012
1112
0.080
Why?
Software
1
2013
280
0.080
Why?
Intestinal Polyps
1
2010
7
0.080
Why?
Receptors, Androgen
1
2010
48
0.080
Why?
Cephalometry
1
2010
18
0.080
Why?
Colorectal Neoplasms
2
2012
302
0.080
Why?
Tumor Microenvironment
1
2012
274
0.080
Why?
Gene Dosage
1
2009
76
0.080
Why?
Carcinoma, Transitional Cell
1
2010
54
0.080
Why?
Head
1
2010
73
0.080
Why?
Intracellular Signaling Peptides and Proteins
1
2010
136
0.070
Why?
Patient Selection
1
2010
273
0.070
Why?
Cell Communication
1
2009
73
0.070
Why?
Age Factors
1
2012
1136
0.070
Why?
Immunohistochemistry
1
2011
975
0.070
Why?
Drug Resistance, Neoplasm
1
2011
350
0.070
Why?
Urinary Bladder Neoplasms
1
2010
167
0.070
Why?
Prospective Studies
4
2017
2412
0.060
Why?
Chromosome Mapping
2
2021
145
0.060
Why?
Prevalence
2
2021
1034
0.060
Why?
Mass Screening
1
2010
362
0.060
Why?
Rural Population
2
2022
597
0.060
Why?
Cell Line, Tumor
4
2011
1470
0.060
Why?
Physical Chromosome Mapping
1
2005
7
0.060
Why?
Antineoplastic Agents
2
2011
1232
0.060
Why?
Frasier Syndrome
1
2005
1
0.060
Why?
Denys-Drash Syndrome
1
2005
2
0.060
Why?
DNA Copy Number Variations
1
2025
117
0.050
Why?
Exons
1
2005
100
0.050
Why?
Counseling
1
2025
141
0.050
Why?
Child
5
2020
7384
0.050
Why?
CpG Islands
1
2024
114
0.050
Why?
Models, Theoretical
1
2005
180
0.050
Why?
Gene Expression Regulation
1
2008
1003
0.050
Why?
Mutation
2
2010
1338
0.050
Why?
Logistic Models
1
2025
947
0.050
Why?
Biopsy
1
2005
600
0.050
Why?
Polyproteins
1
2022
3
0.050
Why?
Child, Preschool
3
2020
4164
0.040
Why?
Smoking Cessation
1
2025
325
0.040
Why?
RNA, Viral
1
2022
123
0.040
Why?
Risk Assessment
2
2021
1368
0.040
Why?
Phosphoproteins
1
2022
117
0.040
Why?
Cardiomyopathy, Hypertrophic, Familial
1
2021
6
0.040
Why?
United States Food and Drug Administration
1
2021
93
0.040
Why?
Membrane Glycoproteins
1
2022
238
0.040
Why?
Nutrition Surveys
1
2021
118
0.040
Why?
Loss of Heterozygosity
2
2012
78
0.040
Why?
Stromal Cells
2
2012
77
0.040
Why?
Nicotine
1
2021
180
0.040
Why?
TOR Serine-Threonine Kinases
2
2010
83
0.040
Why?
Self Report
1
2021
225
0.040
Why?
Pedigree
2
2010
128
0.040
Why?
Seasons
1
2020
92
0.040
Why?
Odds Ratio
1
2021
567
0.040
Why?
Neoplasms
1
2009
1335
0.040
Why?
Air Pollution
1
2020
49
0.040
Why?
Signal Transduction
3
2010
1748
0.040
Why?
Phosphorylation
2
2010
533
0.040
Why?
Gene Expression
2
2012
618
0.040
Why?
Sensitivity and Specificity
2
2012
869
0.040
Why?
Predictive Value of Tests
2
2012
933
0.040
Why?
Pregnancy
1
2025
2610
0.030
Why?
Infant, Newborn
1
2025
2913
0.030
Why?
Infant
2
2020
3808
0.030
Why?
Dose-Response Relationship, Drug
2
2010
1367
0.030
Why?
Angiopoietin-1
1
2017
16
0.030
Why?
Receptor, TIE-2
1
2017
16
0.030
Why?
Angiopoietin-2
1
2017
17
0.030
Why?
Fibroblast Growth Factor 2
1
2017
35
0.030
Why?
Clinical Trials, Phase II as Topic
1
2017
48
0.030
Why?
Matrix Metalloproteinase 9
1
2017
88
0.030
Why?
Vascular Endothelial Growth Factor A
1
2017
189
0.030
Why?
Cross-Sectional Studies
1
2021
1723
0.030
Why?
Neovascularization, Pathologic
1
2017
158
0.030
Why?
Neoadjuvant Therapy
1
2017
124
0.030
Why?
HapMap Project
1
2015
3
0.030
Why?
Introns
1
2015
51
0.030
Why?
Pilot Projects
1
2016
727
0.020
Why?
Peutz-Jeghers Syndrome
1
2013
2
0.020
Why?
Databases, Genetic
1
2013
82
0.020
Why?
Genome, Human
1
2013
121
0.020
Why?
Validation Studies as Topic
1
2012
10
0.020
Why?
Penetrance
1
2012
7
0.020
Why?
Neoplasm Grading
1
2012
128
0.020
Why?
Genetic Association Studies
1
2012
124
0.020
Why?
Vincristine
1
2011
89
0.020
Why?
Anthracyclines
1
2011
35
0.020
Why?
Inhibitory Concentration 50
1
2010
75
0.020
Why?
Formazans
1
2010
2
0.020
Why?
Paclitaxel
1
2011
91
0.020
Why?
Immunoblotting
1
2010
118
0.020
Why?
Tetrazolium Salts
1
2010
13
0.020
Why?
Androgen Antagonists
1
2010
13
0.020
Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
84
0.020
Why?
Drug Synergism
1
2010
147
0.020
Why?
HEK293 Cells
1
2011
235
0.020
Why?
Mitogen-Activated Protein Kinases
1
2010
152
0.020
Why?
Epithelial Cells
1
2012
218
0.020
Why?
Michigan
1
2010
26
0.020
Why?
Ribosomal Protein S6 Kinases, 70-kDa
1
2010
16
0.020
Why?
Point Mutation
1
2010
67
0.020
Why?
Kidney Neoplasms
1
2012
181
0.020
Why?
Neoplasm Transplantation
1
2010
86
0.020
Why?
Androgens
1
2010
70
0.020
Why?
Adenosine Triphosphate
1
2011
211
0.020
Why?
Transplantation, Heterologous
1
2010
78
0.020
Why?
Heredity
1
2009
2
0.020
Why?
Endoscopy, Gastrointestinal
1
2010
73
0.020
Why?
BRCA2 Protein
1
2009
19
0.020
Why?
Polymerase Chain Reaction
1
2011
452
0.020
Why?
Comparative Genomic Hybridization
1
2009
38
0.020
Why?
Proteins
1
2012
351
0.020
Why?
Mice, Nude
1
2010
232
0.020
Why?
BRCA1 Protein
1
2009
39
0.020
Why?
Chi-Square Distribution
1
2010
291
0.020
Why?
Cell Cycle
1
2010
237
0.020
Why?
Protein Binding
1
2011
670
0.020
Why?
Algorithms
1
2013
668
0.020
Why?
Diagnosis, Differential
1
2012
1038
0.020
Why?
Gene Deletion
1
2010
279
0.020
Why?
Cell Survival
1
2010
600
0.020
Why?
Neoplastic Stem Cells
1
2009
90
0.020
Why?
Promoter Regions, Genetic
1
2010
465
0.020
Why?
Neoplasm Invasiveness
1
2009
281
0.020
Why?
Incidence
1
2012
1085
0.020
Why?
Neoplasm Staging
1
2011
774
0.020
Why?
Oligonucleotide Array Sequence Analysis
1
2009
412
0.020
Why?
Membrane Proteins
1
2010
333
0.020
Why?
Microscopy, Confocal
1
2008
75
0.020
Why?
Cell Transformation, Neoplastic
1
2009
187
0.020
Why?
Chromosome Aberrations
1
2009
297
0.020
Why?
Cell Differentiation
1
2011
681
0.020
Why?
Survival Rate
1
2010
949
0.020
Why?
Registries
1
2010
652
0.020
Why?
Treatment Outcome
1
2017
5597
0.010
Why?
Chromosomes, Human
1
2005
41
0.010
Why?
Time Factors
1
2010
2992
0.010
Why?
Reproducibility of Results
1
2005
1221
0.010
Why?
Mice
1
2010
5982
0.010
Why?
Animals
1
2010
13528
0.010
Why?
Orloff's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description